These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17785130)

  • 1. Disabling pansclerotic and plaque morphoea.
    Iqbal MP; Bajaj DR
    J Coll Physicians Surg Pak; 2007 Aug; 17(8):495-6. PubMed ID: 17785130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disabling pansclerotic morphoea of childhood.
    Jamalpur I; Mogili HR; Koratala A
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29455178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PUVA therapy in disabling pansclerotic morphoea of children.
    Scharffetter-Kochanek K; Goldermann R; Lehmann P; Hölzle E; Goerz G
    Br J Dermatol; 1995 May; 132(5):830-1. PubMed ID: 7772497
    [No Abstract]   [Full Text] [Related]  

  • 4. PUVA therapy for disabling pansclerotic morphoea of children.
    Todd DJ; Askari A; Ektaish E
    Br J Dermatol; 1998 Jan; 138(1):201-2. PubMed ID: 9536257
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid response to abatacept in treatment-resistant pansclerotic morphoea.
    Attard M; O'Kane D
    Clin Exp Dermatol; 2022 Apr; 47(4):755-757. PubMed ID: 34798687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disabling pansclerotic morphoea: a case report.
    Tekin NS; Altinyazar HC; Tekin IO; Keskin SI; Kucukoglu R; Onsun N
    Int J Clin Pract; 2010 Jan; 64(1):99-101. PubMed ID: 20089019
    [No Abstract]   [Full Text] [Related]  

  • 7. Low dose UVA1 phototherapy in disabling pansclerotic morphoea of childhood.
    Gruss C; Stücker M; Kobyletzki G; Schreiber D; Altmeyer P; Kerscher M
    Br J Dermatol; 1997 Feb; 136(2):293-4. PubMed ID: 9068760
    [No Abstract]   [Full Text] [Related]  

  • 8. Disabling pansclerotic morphea of childhood with extracutaneous manifestations.
    Kura MM; Jindal SR
    Indian J Dermatol; 2013 Mar; 58(2):159. PubMed ID: 23716826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Linear scleroderma in children (apropos of 27 cases)].
    Larrègue M; Ziegler JE; Lauret P; Bonafe J; Lorette G; Titi A; Ramdenee P; Bressieux JM
    Ann Dermatol Venereol; 1986; 113(3):207-24. PubMed ID: 3752860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Classification of circumscribed scleroderma. A multicenter study of 286 patients. The Scleroderma Study Group of the Society of Dermatologic Research].
    Hautarzt; 1990 Jan; 41(1):16-21. PubMed ID: 2179167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children.
    Roldan R; Morote G; Castro Mdel C; Miranda MD; Moreno JC; Collantes E
    J Rheumatol; 2006 Dec; 33(12):2538-40. PubMed ID: 17143989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult-onset unilateral disabling pansclerotic morphea.
    Singh A; Singhal K; Choudhary S; Bisati S; Arora M
    Indian J Dermatol; 2014 May; 59(3):316. PubMed ID: 24891683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphoea profunda presenting with atrophic skin lesions in a 26 year old female: a case report.
    Giri S; Paudel U; Jha A; Gurung D; Parajuli S
    Clin Med Insights Case Rep; 2012; 5():57-62. PubMed ID: 22661901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disabling pansclerotic morphea: clinical presentation in two adults.
    Maragh SH; Davis MD; Bruce AJ; Nelson AM
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 1):S115-9. PubMed ID: 16021158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear morphoea follows Blaschko's lines.
    Weibel L; Harper JI
    Br J Dermatol; 2008 Jul; 159(1):175-81. PubMed ID: 18503590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagen specific amino acids in skin in localized scleroderma.
    Serup J; Ammitzbøll T; Møller R
    Acta Derm Venereol; 1984; 64(2):99-106. PubMed ID: 6203316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower lip squamous cell carcinoma in disabling pansclerotic morphea of childhood.
    Petrov I; Gantcheva M; Miteva L; Vassileva S; Pramatarov K
    Pediatr Dermatol; 2009; 26(1):59-61. PubMed ID: 19250408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disabling pansclerotic morphea of children.
    Diaz-Perez JL; Connolly SM; Winkelmann RK
    Arch Dermatol; 1980 Feb; 116(2):169-73. PubMed ID: 7356347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical picture of morphea].
    Wojas-Pelc A; Wielowieyska-Szybińska D
    Przegl Lek; 2007; 64(6):438-41. PubMed ID: 18159855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized scleroderma (morphoea): thickness of sclerotic plaques as measured by 15 MHz pulsed ultrasound.
    Serup J
    Acta Derm Venereol; 1984; 64(3):214-9. PubMed ID: 6204482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.